Logo image of EXPI

EXP WORLD HOLDINGS INC (EXPI) Stock Fundamental Analysis

NASDAQ:EXPI - Nasdaq - US30212W1009 - Common Stock - Currency: USD

10.25  +0.14 (+1.43%)

After market: 10.44 +0.19 (+1.85%)

Fundamental Rating

5

EXPI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 64 industry peers in the Real Estate Management & Development industry. EXPI has a great financial health rating, but its profitability evaluates not so good. EXPI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year EXPI has reported negative net income.
In the past year EXPI had a positive cash flow from operations.
In multiple years EXPI reported negative net income over the last 5 years.
EXPI had a positive operating cash flow in each of the past 5 years.
EXPI Yearly Net Income VS EBIT VS OCF VS FCFEXPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

With a Return On Assets value of -3.91%, EXPI perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
EXPI has a Return On Equity (-8.04%) which is comparable to the rest of the industry.
The Return On Invested Capital of EXPI (4.55%) is better than 73.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXPI is below the industry average of 5.64%.
The 3 year average ROIC (3.18%) for EXPI is below the current ROIC(4.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -3.91%
ROE -8.04%
ROIC 4.55%
ROA(3y)-1.25%
ROA(5y)5.75%
ROE(3y)-2.62%
ROE(5y)10.13%
ROIC(3y)3.18%
ROIC(5y)7.72%
EXPI Yearly ROA, ROE, ROICEXPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400 -500

1.3 Margins

EXPI has a Operating Margin (0.27%) which is in line with its industry peers.
In the last couple of years the Operating Margin of EXPI has declined.
EXPI has a Gross Margin of 7.43%. This is in the lower half of the industry: EXPI underperforms 76.56% of its industry peers.
EXPI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.27%
PM (TTM) N/A
GM 7.43%
OM growth 3Y-21.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
EXPI Yearly Profit, Operating, Gross MarginsEXPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXPI is destroying value.
EXPI has less shares outstanding than it did 1 year ago.
EXPI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXPI Yearly Shares OutstandingEXPI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EXPI Yearly Total Debt VS Total AssetsEXPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPI has an Altman-Z score of 14.77. This indicates that EXPI is financially healthy and has little risk of bankruptcy at the moment.
EXPI has a better Altman-Z score (14.77) than 93.75% of its industry peers.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.77
ROIC/WACC0.51
WACC8.86%
EXPI Yearly LT Debt VS Equity VS FCFEXPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

EXPI has a Current Ratio of 1.34. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
EXPI has a Current ratio of 1.34. This is comparable to the rest of the industry: EXPI outperforms 53.13% of its industry peers.
A Quick Ratio of 1.34 indicates that EXPI should not have too much problems paying its short term obligations.
The Quick ratio of EXPI (1.34) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
EXPI Yearly Current Assets VS Current LiabilitesEXPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

EXPI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.86%.
The Revenue has been growing slightly by 6.88% in the past year.
Measured over the past years, EXPI shows a very strong growth in Revenue. The Revenue has been growing by 36.05% on average per year.
EPS 1Y (TTM)-142.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.5%
Revenue 1Y (TTM)6.88%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.05%

3.2 Future

Based on estimates for the next years, EXPI will show a very strong growth in Earnings Per Share. The EPS will grow by 143.10% on average per year.
EXPI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.38% yearly.
EPS Next Y185%
EPS Next 2Y143.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.37%
Revenue Next 2Y3.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPI Yearly Revenue VS EstimatesEXPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
EXPI Yearly EPS VS EstimatesEXPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXPI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 87.38, the valuation of EXPI can be described as expensive.
Based on the Price/Forward Earnings ratio, EXPI is valued a bit cheaper than the industry average as 67.19% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 36.28. EXPI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 87.38
EXPI Price Earnings VS Forward Price EarningsEXPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

EXPI's Enterprise Value to EBITDA is on the same level as the industry average.
EXPI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EXPI is cheaper than 90.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.95
EV/EBITDA 69.68
EXPI Per share dataEXPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPI's earnings are expected to grow with 143.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y143.1%
EPS Next 3YN/A

More info and screens

3

5. Dividend

5.1 Amount

EXPI has a Yearly Dividend Yield of 1.98%. Purely for dividend investing, there may be better candidates out there.
EXPI's Dividend Yield is rather good when compared to the industry average which is at 3.59. EXPI pays more dividend than 89.06% of the companies in the same industry.
EXPI's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.98%

5.2 History

EXPI has been paying a dividend for over 5 years, so it has already some track record.
EXPI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
EXPI Yearly Dividends per shareEXPI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

EXPI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-176.76%
EPS Next 2Y143.1%
EPS Next 3YN/A
EXPI Yearly Income VS Free CF VS DividendEXPI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

More info and screens

EXP WORLD HOLDINGS INC

NASDAQ:EXPI (8/5/2025, 8:13:11 PM)

After market: 10.44 +0.19 (+1.85%)

10.25

+0.14 (+1.43%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)07-31 2025-07-31/dmh
Earnings (Next)11-05 2025-11-05/amc
Inst Owners40.63%
Inst Owner Change-0.72%
Ins Owners43.17%
Ins Owner Change-0.4%
Market Cap1.60B
Analysts80
Price Target12.24 (19.41%)
Short Float %19.72%
Short Ratio15.58
Dividend
Industry RankSector Rank
Dividend Yield 1.98%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-176.76%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-15 2025-08-15 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-440.4%
Min EPS beat(2)-928.9%
Max EPS beat(2)48.1%
EPS beat(4)1
Avg EPS beat(4)-275.84%
Min EPS beat(4)-928.9%
Max EPS beat(4)48.1%
EPS beat(8)2
Avg EPS beat(8)-166.91%
EPS beat(12)3
Avg EPS beat(12)-118.9%
EPS beat(16)7
Avg EPS beat(16)-38.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-5.92%
Max Revenue beat(2)4.39%
Revenue beat(4)1
Avg Revenue beat(4)-2.25%
Min Revenue beat(4)-5.92%
Max Revenue beat(4)4.39%
Revenue beat(8)5
Avg Revenue beat(8)-0.2%
Revenue beat(12)5
Avg Revenue beat(12)-2.14%
Revenue beat(16)9
Avg Revenue beat(16)1.58%
PT rev (1m)11.63%
PT rev (3m)-18.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-85.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.84%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-3.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 87.38
P/S 0.35
P/FCF 9.95
P/OCF 9.4
P/B 7.55
P/tB 8.49
EV/EBITDA 69.68
EPS(TTM)-0.17
EYN/A
EPS(NY)0.12
Fwd EY1.14%
FCF(TTM)1.03
FCFY10.05%
OCF(TTM)1.09
OCFY10.64%
SpS29.32
BVpS1.36
TBVpS1.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.91%
ROE -8.04%
ROCE 5.75%
ROIC 4.55%
ROICexc 4.55%
ROICexgc 5.11%
OM 0.27%
PM (TTM) N/A
GM 7.43%
FCFM 3.51%
ROA(3y)-1.25%
ROA(5y)5.75%
ROE(3y)-2.62%
ROE(5y)10.13%
ROIC(3y)3.18%
ROIC(5y)7.72%
ROICexc(3y)6.94%
ROICexc(5y)19.71%
ROICexgc(3y)9.39%
ROICexgc(5y)31.84%
ROCE(3y)4.02%
ROCE(5y)9.77%
ROICexcg growth 3Y-5.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.79%
ROICexc growth 5YN/A
OM growth 3Y-21.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
F-Score6
Asset Turnover10.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 90.3%
Cap/Sales 0.21%
Interest Coverage 250
Cash Conversion 752.21%
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 14.77
F-Score6
WACC8.86%
ROIC/WACC0.51
Cap/Depr(3y)91.01%
Cap/Depr(5y)129.15%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-142.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-112.5%
EPS Next Y185%
EPS Next 2Y143.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.88%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%1.05%
Revenue Next Year2.37%
Revenue Next 2Y3.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y261.66%
EBIT growth 3Y-16.46%
EBIT growth 5YN/A
EBIT Next Year404.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.99%
FCF growth 3Y-7.69%
FCF growth 5Y29.67%
OCF growth 1Y9.83%
OCF growth 3Y-8.12%
OCF growth 5Y28.25%